Global Biopharmaceutical CDMO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Biopharmaceutical Contract Development and Manufacturing Organizations (CDMOs) are companies that provide comprehensive services for the development and manufacturing of biopharmaceutical products. These organizations play a crucial role in the biopharmaceutical industry by offering a range of services to biotech and pharmaceutical companies, allowing them to outsource various stages of the drug development and manufacturing process.
The global Biopharmaceutical CDMO market size is projected to grow from US$ 27550 million in 2024 to US$ 59300 million in 2030; it is expected to grow at a CAGR of 13.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Biopharmaceutical CDMO Industry Forecast” looks at past sales and reviews total world Biopharmaceutical CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical CDMO sales for 2023 through 2029. With Biopharmaceutical CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical CDMO industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical CDMO.
The core global biopharmaceutical CDMO manufacturers include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim and WuXi AppTech. The top three manufacturers account for approximately 37% of the global share. North America is the world's largest market, accounting for nearly 32% of the market share.
In terms of product type, antibodies occupy a dominant position, accounting for 36% of the market share. At the same time, in terms of application, large companies are the largest application field, accounting for 58%.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biopharmaceutical Contract Development and Manufacturing Organizations (CDMOs) are companies that provide comprehensive services for the development and manufacturing of biopharmaceutical products. These organizations play a crucial role in the biopharmaceutical industry by offering a range of services to biotech and pharmaceutical companies, allowing them to outsource various stages of the drug development and manufacturing process.
The global Biopharmaceutical CDMO market size is projected to grow from US$ 27550 million in 2024 to US$ 59300 million in 2030; it is expected to grow at a CAGR of 13.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Biopharmaceutical CDMO Industry Forecast” looks at past sales and reviews total world Biopharmaceutical CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical CDMO sales for 2023 through 2029. With Biopharmaceutical CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical CDMO industry.
This Insight Report provides a comprehensive analysis of the global Biopharmaceutical CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biopharmaceutical CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biopharmaceutical CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biopharmaceutical CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biopharmaceutical CDMO.
The core global biopharmaceutical CDMO manufacturers include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim and WuXi AppTech. The top three manufacturers account for approximately 37% of the global share. North America is the world's largest market, accounting for nearly 32% of the market share.
In terms of product type, antibodies occupy a dominant position, accounting for 36% of the market share. At the same time, in terms of application, large companies are the largest application field, accounting for 58%.
This report presents a comprehensive overview, market shares, and growth opportunities of Biopharmaceutical CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Other
- SMBs
- Large Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Other
- SMBs
- Large Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Catalent
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- WuXi AppTech
- Recipharm
- Thermo Fisher Scientific
- AGC Biologics
- Rentschler Biopharma
- KBI Biopharma
- Siegfried
- Aenova Group
- GenScript
- ProBioGen
- Northway Biotech
- 3P Biopharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CDMO Market Size 2019-2030
2.1.2 Biopharmaceutical CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biopharmaceutical CDMO by Country/Region, 2019, 2023 & 2030
2.2 Biopharmaceutical CDMO Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Other
2.3 Biopharmaceutical CDMO Market Size by Type
2.3.1 Biopharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
2.4 Biopharmaceutical CDMO Segment by Application
2.4.1 SMBs
2.4.2 Large Companies
2.5 Biopharmaceutical CDMO Market Size by Application
2.5.1 Biopharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
3 BIOPHARMACEUTICAL CDMO MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CDMO Market Size Market Share by Player
3.1.1 Global Biopharmaceutical CDMO Revenue by Player (2019-2024)
3.1.2 Global Biopharmaceutical CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Biopharmaceutical CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO BY REGION
4.1 Biopharmaceutical CDMO Market Size by Region (2019-2024)
4.2 Global Biopharmaceutical CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biopharmaceutical CDMO Market Size Growth (2019-2024)
4.4 APAC Biopharmaceutical CDMO Market Size Growth (2019-2024)
4.5 Europe Biopharmaceutical CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Biopharmaceutical CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biopharmaceutical CDMO Market Size by Country (2019-2024)
5.2 Americas Biopharmaceutical CDMO Market Size by Type (2019-2024)
5.3 Americas Biopharmaceutical CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CDMO Market Size by Region (2019-2024)
6.2 APAC Biopharmaceutical CDMO Market Size by Type (2019-2024)
6.3 APAC Biopharmaceutical CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CDMO Market Size by Country (2019-2024)
7.2 Europe Biopharmaceutical CDMO Market Size by Type (2019-2024)
7.3 Europe Biopharmaceutical CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CDMO by Region (2019-2024)
8.2 Middle East & Africa Biopharmaceutical CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Biopharmaceutical CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CDMO MARKET FORECAST
10.1 Global Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.1.1 Global Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.1.2 Americas Biopharmaceutical CDMO Forecast
10.1.3 APAC Biopharmaceutical CDMO Forecast
10.1.4 Europe Biopharmaceutical CDMO Forecast
10.1.5 Middle East & Africa Biopharmaceutical CDMO Forecast
10.2 Americas Biopharmaceutical CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Biopharmaceutical CDMO Forecast
10.2.2 Canada Market Biopharmaceutical CDMO Forecast
10.2.3 Mexico Market Biopharmaceutical CDMO Forecast
10.2.4 Brazil Market Biopharmaceutical CDMO Forecast
10.3 APAC Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.3.1 China Biopharmaceutical CDMO Market Forecast
10.3.2 Japan Market Biopharmaceutical CDMO Forecast
10.3.3 Korea Market Biopharmaceutical CDMO Forecast
10.3.4 Southeast Asia Market Biopharmaceutical CDMO Forecast
10.3.5 India Market Biopharmaceutical CDMO Forecast
10.3.6 Australia Market Biopharmaceutical CDMO Forecast
10.4 Europe Biopharmaceutical CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Biopharmaceutical CDMO Forecast
10.4.2 France Market Biopharmaceutical CDMO Forecast
10.4.3 UK Market Biopharmaceutical CDMO Forecast
10.4.4 Italy Market Biopharmaceutical CDMO Forecast
10.4.5 Russia Market Biopharmaceutical CDMO Forecast
10.5 Middle East & Africa Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Biopharmaceutical CDMO Forecast
10.5.2 South Africa Market Biopharmaceutical CDMO Forecast
10.5.3 Israel Market Biopharmaceutical CDMO Forecast
10.5.4 Turkey Market Biopharmaceutical CDMO Forecast
10.6 Global Biopharmaceutical CDMO Forecast by Type (2025-2030)
10.7 Global Biopharmaceutical CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biopharmaceutical CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biopharmaceutical CDMO Product Offered
11.1.3 Lonza Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Biopharmaceutical CDMO Product Offered
11.2.3 Catalent Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics Biopharmaceutical CDMO Product Offered
11.3.3 Samsung Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Biopharmaceutical CDMO Product Offered
11.5.3 Boehringer Ingelheim Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Biopharmaceutical CDMO Product Offered
11.6.3 WuXi AppTech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Biopharmaceutical CDMO Product Offered
11.7.3 Recipharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Biopharmaceutical CDMO Product Offered
11.8.3 Thermo Fisher Scientific Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Company Information
11.9.2 AGC Biologics Biopharmaceutical CDMO Product Offered
11.9.3 AGC Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AGC Biologics Main Business Overview
11.9.5 AGC Biologics Latest Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Information
11.10.2 Rentschler Biopharma Biopharmaceutical CDMO Product Offered
11.10.3 Rentschler Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rentschler Biopharma Main Business Overview
11.10.5 Rentschler Biopharma Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Biopharmaceutical CDMO Product Offered
11.11.3 KBI Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Siegfried
11.12.1 Siegfried Company Information
11.12.2 Siegfried Biopharmaceutical CDMO Product Offered
11.12.3 Siegfried Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Siegfried Main Business Overview
11.12.5 Siegfried Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Biopharmaceutical CDMO Product Offered
11.13.3 Aenova Group Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 GenScript
11.14.1 GenScript Company Information
11.14.2 GenScript Biopharmaceutical CDMO Product Offered
11.14.3 GenScript Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 GenScript Main Business Overview
11.14.5 GenScript Latest Developments
11.15 ProBioGen
11.15.1 ProBioGen Company Information
11.15.2 ProBioGen Biopharmaceutical CDMO Product Offered
11.15.3 ProBioGen Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 ProBioGen Main Business Overview
11.15.5 ProBioGen Latest Developments
11.16 Northway Biotech
11.16.1 Northway Biotech Company Information
11.16.2 Northway Biotech Biopharmaceutical CDMO Product Offered
11.16.3 Northway Biotech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Northway Biotech Main Business Overview
11.16.5 Northway Biotech Latest Developments
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Information
11.17.2 3P Biopharmaceuticals Biopharmaceutical CDMO Product Offered
11.17.3 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 3P Biopharmaceuticals Main Business Overview
11.17.5 3P Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biopharmaceutical CDMO Market Size 2019-2030
2.1.2 Biopharmaceutical CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biopharmaceutical CDMO by Country/Region, 2019, 2023 & 2030
2.2 Biopharmaceutical CDMO Segment by Type
2.2.1 Cell and Gene Therapies
2.2.2 Antibodies
2.2.3 Vaccines
2.2.4 Other
2.3 Biopharmaceutical CDMO Market Size by Type
2.3.1 Biopharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
2.4 Biopharmaceutical CDMO Segment by Application
2.4.1 SMBs
2.4.2 Large Companies
2.5 Biopharmaceutical CDMO Market Size by Application
2.5.1 Biopharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
3 BIOPHARMACEUTICAL CDMO MARKET SIZE BY PLAYER
3.1 Biopharmaceutical CDMO Market Size Market Share by Player
3.1.1 Global Biopharmaceutical CDMO Revenue by Player (2019-2024)
3.1.2 Global Biopharmaceutical CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Biopharmaceutical CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CDMO BY REGION
4.1 Biopharmaceutical CDMO Market Size by Region (2019-2024)
4.2 Global Biopharmaceutical CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biopharmaceutical CDMO Market Size Growth (2019-2024)
4.4 APAC Biopharmaceutical CDMO Market Size Growth (2019-2024)
4.5 Europe Biopharmaceutical CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Biopharmaceutical CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biopharmaceutical CDMO Market Size by Country (2019-2024)
5.2 Americas Biopharmaceutical CDMO Market Size by Type (2019-2024)
5.3 Americas Biopharmaceutical CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceutical CDMO Market Size by Region (2019-2024)
6.2 APAC Biopharmaceutical CDMO Market Size by Type (2019-2024)
6.3 APAC Biopharmaceutical CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biopharmaceutical CDMO Market Size by Country (2019-2024)
7.2 Europe Biopharmaceutical CDMO Market Size by Type (2019-2024)
7.3 Europe Biopharmaceutical CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biopharmaceutical CDMO by Region (2019-2024)
8.2 Middle East & Africa Biopharmaceutical CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Biopharmaceutical CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOPHARMACEUTICAL CDMO MARKET FORECAST
10.1 Global Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.1.1 Global Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.1.2 Americas Biopharmaceutical CDMO Forecast
10.1.3 APAC Biopharmaceutical CDMO Forecast
10.1.4 Europe Biopharmaceutical CDMO Forecast
10.1.5 Middle East & Africa Biopharmaceutical CDMO Forecast
10.2 Americas Biopharmaceutical CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Biopharmaceutical CDMO Forecast
10.2.2 Canada Market Biopharmaceutical CDMO Forecast
10.2.3 Mexico Market Biopharmaceutical CDMO Forecast
10.2.4 Brazil Market Biopharmaceutical CDMO Forecast
10.3 APAC Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.3.1 China Biopharmaceutical CDMO Market Forecast
10.3.2 Japan Market Biopharmaceutical CDMO Forecast
10.3.3 Korea Market Biopharmaceutical CDMO Forecast
10.3.4 Southeast Asia Market Biopharmaceutical CDMO Forecast
10.3.5 India Market Biopharmaceutical CDMO Forecast
10.3.6 Australia Market Biopharmaceutical CDMO Forecast
10.4 Europe Biopharmaceutical CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Biopharmaceutical CDMO Forecast
10.4.2 France Market Biopharmaceutical CDMO Forecast
10.4.3 UK Market Biopharmaceutical CDMO Forecast
10.4.4 Italy Market Biopharmaceutical CDMO Forecast
10.4.5 Russia Market Biopharmaceutical CDMO Forecast
10.5 Middle East & Africa Biopharmaceutical CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Biopharmaceutical CDMO Forecast
10.5.2 South Africa Market Biopharmaceutical CDMO Forecast
10.5.3 Israel Market Biopharmaceutical CDMO Forecast
10.5.4 Turkey Market Biopharmaceutical CDMO Forecast
10.6 Global Biopharmaceutical CDMO Forecast by Type (2025-2030)
10.7 Global Biopharmaceutical CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biopharmaceutical CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biopharmaceutical CDMO Product Offered
11.1.3 Lonza Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Biopharmaceutical CDMO Product Offered
11.2.3 Catalent Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Information
11.3.2 Samsung Biologics Biopharmaceutical CDMO Product Offered
11.3.3 Samsung Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Samsung Biologics Main Business Overview
11.3.5 Samsung Biologics Latest Developments
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
11.4.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Product Offered
11.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Information
11.5.2 Boehringer Ingelheim Biopharmaceutical CDMO Product Offered
11.5.3 Boehringer Ingelheim Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Boehringer Ingelheim Main Business Overview
11.5.5 Boehringer Ingelheim Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Biopharmaceutical CDMO Product Offered
11.6.3 WuXi AppTech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Biopharmaceutical CDMO Product Offered
11.7.3 Recipharm Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Biopharmaceutical CDMO Product Offered
11.8.3 Thermo Fisher Scientific Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 AGC Biologics
11.9.1 AGC Biologics Company Information
11.9.2 AGC Biologics Biopharmaceutical CDMO Product Offered
11.9.3 AGC Biologics Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AGC Biologics Main Business Overview
11.9.5 AGC Biologics Latest Developments
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Information
11.10.2 Rentschler Biopharma Biopharmaceutical CDMO Product Offered
11.10.3 Rentschler Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Rentschler Biopharma Main Business Overview
11.10.5 Rentschler Biopharma Latest Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Information
11.11.2 KBI Biopharma Biopharmaceutical CDMO Product Offered
11.11.3 KBI Biopharma Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 KBI Biopharma Main Business Overview
11.11.5 KBI Biopharma Latest Developments
11.12 Siegfried
11.12.1 Siegfried Company Information
11.12.2 Siegfried Biopharmaceutical CDMO Product Offered
11.12.3 Siegfried Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Siegfried Main Business Overview
11.12.5 Siegfried Latest Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Information
11.13.2 Aenova Group Biopharmaceutical CDMO Product Offered
11.13.3 Aenova Group Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Aenova Group Main Business Overview
11.13.5 Aenova Group Latest Developments
11.14 GenScript
11.14.1 GenScript Company Information
11.14.2 GenScript Biopharmaceutical CDMO Product Offered
11.14.3 GenScript Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 GenScript Main Business Overview
11.14.5 GenScript Latest Developments
11.15 ProBioGen
11.15.1 ProBioGen Company Information
11.15.2 ProBioGen Biopharmaceutical CDMO Product Offered
11.15.3 ProBioGen Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 ProBioGen Main Business Overview
11.15.5 ProBioGen Latest Developments
11.16 Northway Biotech
11.16.1 Northway Biotech Company Information
11.16.2 Northway Biotech Biopharmaceutical CDMO Product Offered
11.16.3 Northway Biotech Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Northway Biotech Main Business Overview
11.16.5 Northway Biotech Latest Developments
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Information
11.17.2 3P Biopharmaceuticals Biopharmaceutical CDMO Product Offered
11.17.3 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 3P Biopharmaceuticals Main Business Overview
11.17.5 3P Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biopharmaceutical CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Biopharmaceutical CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Other
Table 7. Biopharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 10. Biopharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 13. Global Biopharmaceutical CDMO Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Biopharmaceutical CDMO Revenue Market Share by Player (2019-2024)
Table 15. Biopharmaceutical CDMO Key Players Head office and Products Offered
Table 16. Biopharmaceutical CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biopharmaceutical CDMO Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 21. Global Biopharmaceutical CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biopharmaceutical CDMO Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biopharmaceutical CDMO Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Biopharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 25. Americas Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 27. Americas Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 29. APAC Biopharmaceutical CDMO Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 31. APAC Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Biopharmaceutical CDMO Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Biopharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 35. Europe Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Biopharmaceutical CDMO Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biopharmaceutical CDMO
Table 41. Key Market Challenges & Risks of Biopharmaceutical CDMO
Table 42. Key Industry Trends of Biopharmaceutical CDMO
Table 43. Global Biopharmaceutical CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Biopharmaceutical CDMO Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Biopharmaceutical CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Biopharmaceutical CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Lonza Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 48. Lonza Biopharmaceutical CDMO Product Offered
Table 49. Lonza Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 53. Catalent Biopharmaceutical CDMO Product Offered
Table 54. Catalent Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Samsung Biologics Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 58. Samsung Biologics Biopharmaceutical CDMO Product Offered
Table 59. Samsung Biologics Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Samsung Biologics Main Business
Table 61. Samsung Biologics Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 63. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Product Offered
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. FUJIFILM Diosynth Biotechnologies Main Business
Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 68. Boehringer Ingelheim Biopharmaceutical CDMO Product Offered
Table 69. Boehringer Ingelheim Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Boehringer Ingelheim Main Business
Table 71. Boehringer Ingelheim Latest Developments
Table 72. WuXi AppTech Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 73. WuXi AppTech Biopharmaceutical CDMO Product Offered
Table 74. WuXi AppTech Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. WuXi AppTech Main Business
Table 76. WuXi AppTech Latest Developments
Table 77. Recipharm Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 78. Recipharm Biopharmaceutical CDMO Product Offered
Table 79. Recipharm Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Recipharm Main Business
Table 81. Recipharm Latest Developments
Table 82. Thermo Fisher Scientific Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 83. Thermo Fisher Scientific Biopharmaceutical CDMO Product Offered
Table 84. Thermo Fisher Scientific Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Latest Developments
Table 87. AGC Biologics Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 88. AGC Biologics Biopharmaceutical CDMO Product Offered
Table 89. AGC Biologics Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. AGC Biologics Main Business
Table 91. AGC Biologics Latest Developments
Table 92. Rentschler Biopharma Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 93. Rentschler Biopharma Biopharmaceutical CDMO Product Offered
Table 94. Rentschler Biopharma Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Rentschler Biopharma Main Business
Table 96. Rentschler Biopharma Latest Developments
Table 97. KBI Biopharma Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 98. KBI Biopharma Biopharmaceutical CDMO Product Offered
Table 99. KBI Biopharma Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. KBI Biopharma Main Business
Table 101. KBI Biopharma Latest Developments
Table 102. Siegfried Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 103. Siegfried Biopharmaceutical CDMO Product Offered
Table 104. Siegfried Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Siegfried Main Business
Table 106. Siegfried Latest Developments
Table 107. Aenova Group Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 108. Aenova Group Biopharmaceutical CDMO Product Offered
Table 109. Aenova Group Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Aenova Group Main Business
Table 111. Aenova Group Latest Developments
Table 112. GenScript Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 113. GenScript Biopharmaceutical CDMO Product Offered
Table 114. GenScript Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. GenScript Main Business
Table 116. GenScript Latest Developments
Table 117. ProBioGen Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 118. ProBioGen Biopharmaceutical CDMO Product Offered
Table 119. ProBioGen Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. ProBioGen Main Business
Table 121. ProBioGen Latest Developments
Table 122. Northway Biotech Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 123. Northway Biotech Biopharmaceutical CDMO Product Offered
Table 124. Northway Biotech Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Northway Biotech Main Business
Table 126. Northway Biotech Latest Developments
Table 127. 3P Biopharmaceuticals Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 128. 3P Biopharmaceuticals Biopharmaceutical CDMO Product Offered
Table 129. 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. 3P Biopharmaceuticals Main Business
Table 131. 3P Biopharmaceuticals Latest Developments
Table 1. Biopharmaceutical CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Biopharmaceutical CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cell and Gene Therapies
Table 4. Major Players of Antibodies
Table 5. Major Players of Vaccines
Table 6. Major Players of Other
Table 7. Biopharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 10. Biopharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 13. Global Biopharmaceutical CDMO Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Biopharmaceutical CDMO Revenue Market Share by Player (2019-2024)
Table 15. Biopharmaceutical CDMO Key Players Head office and Products Offered
Table 16. Biopharmaceutical CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biopharmaceutical CDMO Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 21. Global Biopharmaceutical CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Biopharmaceutical CDMO Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Biopharmaceutical CDMO Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Biopharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 25. Americas Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 27. Americas Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 29. APAC Biopharmaceutical CDMO Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 31. APAC Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Biopharmaceutical CDMO Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Biopharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 35. Europe Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Biopharmaceutical CDMO Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Biopharmaceutical CDMO Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Biopharmaceutical CDMO Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Biopharmaceutical CDMO
Table 41. Key Market Challenges & Risks of Biopharmaceutical CDMO
Table 42. Key Industry Trends of Biopharmaceutical CDMO
Table 43. Global Biopharmaceutical CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Biopharmaceutical CDMO Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Biopharmaceutical CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Biopharmaceutical CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. Lonza Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 48. Lonza Biopharmaceutical CDMO Product Offered
Table 49. Lonza Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. Lonza Main Business
Table 51. Lonza Latest Developments
Table 52. Catalent Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 53. Catalent Biopharmaceutical CDMO Product Offered
Table 54. Catalent Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Catalent Main Business
Table 56. Catalent Latest Developments
Table 57. Samsung Biologics Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 58. Samsung Biologics Biopharmaceutical CDMO Product Offered
Table 59. Samsung Biologics Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Samsung Biologics Main Business
Table 61. Samsung Biologics Latest Developments
Table 62. FUJIFILM Diosynth Biotechnologies Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 63. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Product Offered
Table 64. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. FUJIFILM Diosynth Biotechnologies Main Business
Table 66. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 67. Boehringer Ingelheim Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 68. Boehringer Ingelheim Biopharmaceutical CDMO Product Offered
Table 69. Boehringer Ingelheim Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Boehringer Ingelheim Main Business
Table 71. Boehringer Ingelheim Latest Developments
Table 72. WuXi AppTech Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 73. WuXi AppTech Biopharmaceutical CDMO Product Offered
Table 74. WuXi AppTech Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. WuXi AppTech Main Business
Table 76. WuXi AppTech Latest Developments
Table 77. Recipharm Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 78. Recipharm Biopharmaceutical CDMO Product Offered
Table 79. Recipharm Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Recipharm Main Business
Table 81. Recipharm Latest Developments
Table 82. Thermo Fisher Scientific Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 83. Thermo Fisher Scientific Biopharmaceutical CDMO Product Offered
Table 84. Thermo Fisher Scientific Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Latest Developments
Table 87. AGC Biologics Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 88. AGC Biologics Biopharmaceutical CDMO Product Offered
Table 89. AGC Biologics Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. AGC Biologics Main Business
Table 91. AGC Biologics Latest Developments
Table 92. Rentschler Biopharma Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 93. Rentschler Biopharma Biopharmaceutical CDMO Product Offered
Table 94. Rentschler Biopharma Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Rentschler Biopharma Main Business
Table 96. Rentschler Biopharma Latest Developments
Table 97. KBI Biopharma Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 98. KBI Biopharma Biopharmaceutical CDMO Product Offered
Table 99. KBI Biopharma Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. KBI Biopharma Main Business
Table 101. KBI Biopharma Latest Developments
Table 102. Siegfried Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 103. Siegfried Biopharmaceutical CDMO Product Offered
Table 104. Siegfried Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Siegfried Main Business
Table 106. Siegfried Latest Developments
Table 107. Aenova Group Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 108. Aenova Group Biopharmaceutical CDMO Product Offered
Table 109. Aenova Group Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Aenova Group Main Business
Table 111. Aenova Group Latest Developments
Table 112. GenScript Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 113. GenScript Biopharmaceutical CDMO Product Offered
Table 114. GenScript Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. GenScript Main Business
Table 116. GenScript Latest Developments
Table 117. ProBioGen Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 118. ProBioGen Biopharmaceutical CDMO Product Offered
Table 119. ProBioGen Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. ProBioGen Main Business
Table 121. ProBioGen Latest Developments
Table 122. Northway Biotech Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 123. Northway Biotech Biopharmaceutical CDMO Product Offered
Table 124. Northway Biotech Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Northway Biotech Main Business
Table 126. Northway Biotech Latest Developments
Table 127. 3P Biopharmaceuticals Details, Company Type, Biopharmaceutical CDMO Area Served and Its Competitors
Table 128. 3P Biopharmaceuticals Biopharmaceutical CDMO Product Offered
Table 129. 3P Biopharmaceuticals Biopharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. 3P Biopharmaceuticals Main Business
Table 131. 3P Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Biopharmaceutical CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Biopharmaceutical CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biopharmaceutical CDMO Sales Market Share by Country/Region (2023)
Figure 8. Biopharmaceutical CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biopharmaceutical CDMO Market Size Market Share by Type in 2023
Figure 10. Biopharmaceutical CDMO in SMBs
Figure 11. Global Biopharmaceutical CDMO Market: SMBs (2019-2024) & ($ millions)
Figure 12. Biopharmaceutical CDMO in Large Companies
Figure 13. Global Biopharmaceutical CDMO Market: Large Companies (2019-2024) & ($ millions)
Figure 14. Global Biopharmaceutical CDMO Market Size Market Share by Application in 2023
Figure 15. Global Biopharmaceutical CDMO Revenue Market Share by Player in 2023
Figure 16. Global Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Figure 17. Americas Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 18. APAC Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 19. Europe Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 21. Americas Biopharmaceutical CDMO Value Market Share by Country in 2023
Figure 22. United States Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Biopharmaceutical CDMO Market Size Market Share by Region in 2023
Figure 27. APAC Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 28. APAC Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 29. China Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 33. India Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Biopharmaceutical CDMO Market Size Market Share by Country in 2023
Figure 36. Europe Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 37. Europe Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 38. Germany Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 39. France Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 52. APAC Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 53. Europe Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 55. United States Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 56. Canada Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 57. Mexico Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 58. Brazil Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 59. China Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 60. Japan Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 61. Korea Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 63. India Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 64. Australia Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 65. Germany Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 66. France Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 67. UK Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 68. Italy Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 69. Russia Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 70. Egypt Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 71. South Africa Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 72. Israel Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 73. Turkey Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 75. Global Biopharmaceutical CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Biopharmaceutical CDMO Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biopharmaceutical CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biopharmaceutical CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Biopharmaceutical CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biopharmaceutical CDMO Sales Market Share by Country/Region (2023)
Figure 8. Biopharmaceutical CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biopharmaceutical CDMO Market Size Market Share by Type in 2023
Figure 10. Biopharmaceutical CDMO in SMBs
Figure 11. Global Biopharmaceutical CDMO Market: SMBs (2019-2024) & ($ millions)
Figure 12. Biopharmaceutical CDMO in Large Companies
Figure 13. Global Biopharmaceutical CDMO Market: Large Companies (2019-2024) & ($ millions)
Figure 14. Global Biopharmaceutical CDMO Market Size Market Share by Application in 2023
Figure 15. Global Biopharmaceutical CDMO Revenue Market Share by Player in 2023
Figure 16. Global Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Figure 17. Americas Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 18. APAC Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 19. Europe Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Biopharmaceutical CDMO Market Size 2019-2024 ($ millions)
Figure 21. Americas Biopharmaceutical CDMO Value Market Share by Country in 2023
Figure 22. United States Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Biopharmaceutical CDMO Market Size Market Share by Region in 2023
Figure 27. APAC Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 28. APAC Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 29. China Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 33. India Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Biopharmaceutical CDMO Market Size Market Share by Country in 2023
Figure 36. Europe Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 37. Europe Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 38. Germany Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 39. France Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Biopharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Biopharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Biopharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Biopharmaceutical CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 52. APAC Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 53. Europe Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 55. United States Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 56. Canada Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 57. Mexico Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 58. Brazil Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 59. China Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 60. Japan Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 61. Korea Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 63. India Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 64. Australia Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 65. Germany Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 66. France Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 67. UK Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 68. Italy Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 69. Russia Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 70. Egypt Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 71. South Africa Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 72. Israel Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 73. Turkey Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Biopharmaceutical CDMO Market Size 2025-2030 ($ millions)
Figure 75. Global Biopharmaceutical CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Biopharmaceutical CDMO Market Size Market Share Forecast by Application (2025-2030)
